These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 16863518
1. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Sadeghian G, Nilforoushzadeh MA. Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518 [Abstract] [Full Text] [Related]
2. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis. Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A. J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655 [Abstract] [Full Text] [Related]
5. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. Salmanpour R, Handjani F, Nouhpisheh MK. J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707 [Abstract] [Full Text] [Related]
9. Allopurinol in the treatment of American cutaneous leishmaniasis. Martinez S, Marr JJ. N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379 [Abstract] [Full Text] [Related]
13. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice. Nilforoushzadeh MA, Shirani-Bidabadi L, Zolfaghari-Baghbaderani A, Saberi S, Siadat AH, Mahmoudi M. J Vector Borne Dis; 2008 Dec 12; 45(4):301-6. PubMed ID: 19248657 [Abstract] [Full Text] [Related]
14. Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis. Firdous R, Yasinzai M, Ranja K. Int J Dermatol; 2009 Jul 12; 48(7):758-62. PubMed ID: 19570087 [Abstract] [Full Text] [Related]
16. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate. Neves DB, Caldas ED, Sampaio RN. Trop Med Int Health; 2009 Dec 12; 14(12):1515-22. PubMed ID: 19954451 [Abstract] [Full Text] [Related]
17. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD. Am J Trop Med Hyg; 2005 Feb 12; 72(2):133-7. PubMed ID: 15741547 [Abstract] [Full Text] [Related]
18. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran. Mohammadzadeh M, Behnaz F, Golshan Z. J Infect Public Health; 2013 Apr 12; 6(2):120-4. PubMed ID: 23537825 [Abstract] [Full Text] [Related]
19. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Machado PR, Lessa H, Lessa M, Guimarães LH, Bang H, Ho JL, Carvalho EM. Clin Infect Dis; 2007 Mar 15; 44(6):788-93. PubMed ID: 17304449 [Abstract] [Full Text] [Related]